$9.11
0.091.00%
At close: -
$8.97
-0.14-1.54%
After Hours: Nov 22, 7:59 PM EDT
Anavex Life Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Anavex Life Sciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.14 | $-0.13 | -7.69 % |
Mar 2024 | 2024-05-09 | $-0.13 | $-0.11 | -18.2 % |
Dec 2023 | 2024-02-07 | $-0.11 | $-0.14 | 21.4 % |
Sep 2023 | 2023-11-27 | $-0.12 | $-0.15 | 20.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Anavex Life Sciences (AVXL) is scheduled to report earnings on February 5, 2025. The last reported earnings were for reported on August 6, 2024 for Q3.
The Actual EPS was $-0.14, which missed the estimate of $-0.13.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.